- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.75 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x GIV- SIA: N-acetyl-alpha-neuraminic acid-(2-3)-beta-L-galactopyranose(Non-covalent)
- 25 x SO4: SULFATE ION(Non-functional Binders)
- 14 x GOL: GLYCEROL(Non-functional Binders)
GOL.17: 5 residues within 4Å:- Chain A: H.223, R.224, Q.325, T.486
- Ligands: NA.84
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:R.224, A:Q.325, A:Q.325
- Water bridges: A:R.224
GOL.18: 6 residues within 4Å:- Chain A: P.52, L.178, Q.181, W.182, E.185, N.186
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.186
GOL.19: 5 residues within 4Å:- Chain A: G.240, M.241, G.242, E.243
- Ligands: CL.41
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:G.242, A:E.243
GOL.20: 9 residues within 4Å:- Chain A: L.33, T.63, T.64, F.65, R.90, D.134, R.136
- Ligands: SO4.9, SO4.14
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:T.63, A:T.64, A:R.90, A:D.134, A:R.136
GOL.21: 3 residues within 4Å:- Chain A: R.478
- Ligands: NA.86, NA.87
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.478
GOL.22: 5 residues within 4Å:- Chain A: R.165, G.264, N.265, D.266, T.267
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:R.165, A:G.264, A:D.266, A:T.267, A:T.267
GOL.23: 2 residues within 4Å:- Chain A: T.11, R.16
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:T.11, A:R.16
GOL.24: 5 residues within 4Å:- Chain A: R.475, Y.479, A.497
- Ligands: NA.87, NA.92
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Y.479, A:Y.479
GOL.25: 6 residues within 4Å:- Chain A: L.386, H.387, P.388, E.389, D.390
- Ligands: EPE.26
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.389, A:D.390
GOL.119: 3 residues within 4Å:- Chain B: L.22, K.23, R.136
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:K.23, B:R.136
GOL.120: 5 residues within 4Å:- Chain B: M.42, Y.70, S.93, E.94
- Ligands: CL.139
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.94, B:E.94, B:E.94
GOL.121: 9 residues within 4Å:- Chain B: L.213, L.214, P.216, R.219, L.315, A.318, G.319, D.320
- Ligands: NA.158
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:L.214, B:R.219, B:A.318
GOL.123: 2 residues within 4Å:- Chain B: Q.291, Q.369
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Q.291, B:Q.369
GOL.124: 2 residues within 4Å:- Chain B: P.440, L.441
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.438
- 2 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
EPE.26: 5 residues within 4Å:- Chain A: H.387, D.390, R.393
- Chain B: R.522
- Ligands: GOL.25
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain B- Salt bridges: A:D.390, A:R.393
- Hydrogen bonds: B:R.522, B:R.522
EPE.122: 7 residues within 4Å:- Chain B: V.239, G.240, M.241, G.242, E.243, R.246
- Ligands: CL.142
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:G.240, B:M.241, B:G.242
- 1 x 01: 2-[(~{Z})-hydroxyiminomethyl]-6-[4-(quinolin-4-ylamino)butyl]pyridin-3-ol
01.27: 23 residues within 4Å:- Chain A: E.81, G.82, M.85, W.86, G.120, Y.133, E.202, Y.337, L.437, S.438, W.439, P.446, H.447, G.448, Y.449, I.451, E.452
- Ligands: CL.44, NA.74, NA.77, NA.82, NA.90, NA.91
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:W.86, A:Y.337, A:Y.337, A:W.439, A:P.446, A:I.451
- Hydrogen bonds: A:E.81, A:E.81, A:H.447
- Water bridges: A:E.452, A:E.452
- pi-Stacking: A:W.86, A:W.86, A:W.86, A:Y.449
- 43 x CL: CHLORIDE ION(Non-functional Binders)
CL.28: 7 residues within 4Å:- Chain A: R.525, A.526, Q.527, A.528
- Ligands: CL.29, CL.40, NA.48
Ligand excluded by PLIPCL.29: 5 residues within 4Å:- Chain A: A.526
- Chain B: L.386
- Ligands: CL.28, CL.39, NA.49
Ligand excluded by PLIPCL.30: 2 residues within 4Å:- Chain A: K.332
- Ligands: NA.81
Ligand excluded by PLIPCL.31: 3 residues within 4Å:- Chain A: F.80, K.348
- Ligands: NA.72
Ligand excluded by PLIPCL.32: 3 residues within 4Å:- Chain A: G.240, E.243
- Ligands: NA.61
Ligand excluded by PLIPCL.33: 5 residues within 4Å:- Chain A: N.490, E.491, D.494, A.497, Q.499
Ligand excluded by PLIPCL.34: 2 residues within 4Å:- Chain A: P.495
- Ligands: CL.35
Ligand excluded by PLIPCL.35: 3 residues within 4Å:- Chain A: P.495
- Ligands: CL.34, CL.36
Ligand excluded by PLIPCL.36: 3 residues within 4Å:- Chain A: Q.499
- Ligands: CL.35, NA.51
Ligand excluded by PLIPCL.37: 3 residues within 4Å:- Chain A: W.286, Q.291
- Ligands: NA.52
Ligand excluded by PLIPCL.38: 1 residues within 4Å:- Chain A: R.424
Ligand excluded by PLIPCL.39: 5 residues within 4Å:- Chain A: G.523, R.525
- Ligands: CL.29, NA.49, NA.81
Ligand excluded by PLIPCL.40: 4 residues within 4Å:- Chain A: R.525
- Ligands: CL.28, NA.48, NA.49
Ligand excluded by PLIPCL.41: 2 residues within 4Å:- Chain A: R.246
- Ligands: GOL.19
Ligand excluded by PLIPCL.42: 5 residues within 4Å:- Chain A: F.297
- Ligands: NA.47, NA.69, MG.95, MG.96
Ligand excluded by PLIPCL.43: 6 residues within 4Å:- Chain A: E.243, R.246, R.247, Q.250, V.288
- Ligands: NA.73
Ligand excluded by PLIPCL.44: 5 residues within 4Å:- Chain A: Y.124, S.203
- Ligands: 01.27, NA.77, MG.96
Ligand excluded by PLIPCL.45: 6 residues within 4Å:- Chain A: C.409, P.410, Q.413, N.533
- Ligands: NA.88, MG.104
Ligand excluded by PLIPCL.46: 4 residues within 4Å:- Chain A: M.85, V.132, R.463
- Ligands: NA.91
Ligand excluded by PLIPCL.126: 1 residues within 4Å:- Ligands: NA.150
Ligand excluded by PLIPCL.127: 4 residues within 4Å:- Chain B: Y.124, E.285, S.298, F.299
Ligand excluded by PLIPCL.128: 4 residues within 4Å:- Chain A: H.381
- Chain B: H.381
- Ligands: NA.60, NA.67
Ligand excluded by PLIPCL.129: 1 residues within 4Å:- Chain B: R.478
Ligand excluded by PLIPCL.130: 4 residues within 4Å:- Chain B: R.219
- Ligands: CL.133, NA.156, NA.159
Ligand excluded by PLIPCL.131: 4 residues within 4Å:- Chain B: W.286, S.293
- Ligands: NA.163, NA.173
Ligand excluded by PLIPCL.132: 4 residues within 4Å:- Chain B: T.195, F.222, H.223
- Ligands: NA.159
Ligand excluded by PLIPCL.133: 4 residues within 4Å:- Chain B: R.219, F.222
- Ligands: CL.130, NA.159
Ligand excluded by PLIPCL.134: 2 residues within 4Å:- Chain B: P.235
- Ligands: NA.154
Ligand excluded by PLIPCL.135: 1 residues within 4Å:- Ligands: NA.153
Ligand excluded by PLIPCL.136: 3 residues within 4Å:- Chain B: R.296, P.368, H.405
Ligand excluded by PLIPCL.137: 3 residues within 4Å:- Chain B: P.290, Q.291, S.293
Ligand excluded by PLIPCL.138: 6 residues within 4Å:- Chain B: L.339, V.340, Y.341, G.342, A.343, F.346
Ligand excluded by PLIPCL.139: 4 residues within 4Å:- Chain B: A.278
- Ligands: GOL.120, CL.140, NA.164
Ligand excluded by PLIPCL.140: 4 residues within 4Å:- Chain B: R.274, T.275, R.276
- Ligands: CL.139
Ligand excluded by PLIPCL.141: 2 residues within 4Å:- Chain B: A.271, R.274
Ligand excluded by PLIPCL.142: 2 residues within 4Å:- Chain B: T.238
- Ligands: EPE.122
Ligand excluded by PLIPCL.143: 4 residues within 4Å:- Chain B: G.323, Q.325, R.424
- Ligands: NA.160
Ligand excluded by PLIPCL.144: 4 residues within 4Å:- Chain B: E.81, T.436, E.452
- Ligands: NA.174
Ligand excluded by PLIPCL.145: 3 residues within 4Å:- Chain B: Q.184, P.194, T.195
Ligand excluded by PLIPCL.146: 6 residues within 4Å:- Chain A: L.386
- Chain B: G.523, A.526
- Ligands: NA.50, MG.98, SO4.116
Ligand excluded by PLIPCL.147: 2 residues within 4Å:- Chain B: S.203
- Ligands: ACT.125
Ligand excluded by PLIPCL.148: 4 residues within 4Å:- Chain B: L.76, Y.77, V.340, Y.341
Ligand excluded by PLIPCL.149: 2 residues within 4Å:- Chain B: R.90, E.91
Ligand excluded by PLIP- 82 x NA: SODIUM ION(Non-functional Binders)
NA.47: 6 residues within 4Å:- Chain A: W.286, F.295, R.296
- Ligands: CL.42, NA.69, MG.95
Ligand excluded by PLIPNA.48: 3 residues within 4Å:- Chain A: R.525
- Ligands: CL.28, CL.40
Ligand excluded by PLIPNA.49: 3 residues within 4Å:- Ligands: CL.29, CL.39, CL.40
Ligand excluded by PLIPNA.50: 2 residues within 4Å:- Ligands: MG.98, CL.146
Ligand excluded by PLIPNA.51: 2 residues within 4Å:- Chain A: Q.499
- Ligands: CL.36
Ligand excluded by PLIPNA.52: 2 residues within 4Å:- Chain A: E.292
- Ligands: CL.37
Ligand excluded by PLIPNA.53: 5 residues within 4Å:- Chain A: A.412, L.524, A.526, C.529
- Ligands: SO4.15
Ligand excluded by PLIPNA.54: 2 residues within 4Å:- Chain A: P.277, A.278
Ligand excluded by PLIPNA.55: 4 residues within 4Å:- Chain A: H.322, G.323, L.324, G.422
Ligand excluded by PLIPNA.56: 4 residues within 4Å:- Chain A: R.247, R.296, F.297
- Ligands: NA.57
Ligand excluded by PLIPNA.57: 5 residues within 4Å:- Chain A: P.235, T.238, V.239
- Ligands: NA.56, NA.61
Ligand excluded by PLIPNA.58: 4 residues within 4Å:- Chain A: R.247, Q.291
- Ligands: NA.61, NA.62
Ligand excluded by PLIPNA.59: 4 residues within 4Å:- Chain A: L.380
- Chain B: H.381, Q.527
- Ligands: NA.60
Ligand excluded by PLIPNA.60: 5 residues within 4Å:- Chain A: H.381
- Chain B: Q.527
- Ligands: NA.59, NA.70, CL.128
Ligand excluded by PLIPNA.61: 4 residues within 4Å:- Ligands: CL.32, NA.57, NA.58, NA.62
Ligand excluded by PLIPNA.62: 5 residues within 4Å:- Chain A: R.296, P.368
- Ligands: NA.58, NA.61, MG.100
Ligand excluded by PLIPNA.63: 1 residues within 4Å:- Chain A: W.286
Ligand excluded by PLIPNA.64: 2 residues within 4Å:- Chain A: W.286, H.287
Ligand excluded by PLIPNA.65: 2 residues within 4Å:- Chain A: A.505
- Ligands: SO4.15
Ligand excluded by PLIPNA.66: 6 residues within 4Å:- Chain A: A.419, A.423, R.424, V.425, P.502, Y.503
Ligand excluded by PLIPNA.67: 4 residues within 4Å:- Chain A: Q.527
- Chain B: H.381, T.383
- Ligands: CL.128
Ligand excluded by PLIPNA.68: 2 residues within 4Å:- Chain A: E.376
- Chain B: R.534
Ligand excluded by PLIPNA.69: 6 residues within 4Å:- Chain A: V.294, F.295, F.338
- Ligands: CL.42, NA.47, NA.71
Ligand excluded by PLIPNA.70: 2 residues within 4Å:- Chain A: H.381
- Ligands: NA.60
Ligand excluded by PLIPNA.71: 5 residues within 4Å:- Chain A: S.293, V.294, Y.341, G.342
- Ligands: NA.69
Ligand excluded by PLIPNA.72: 3 residues within 4Å:- Chain A: G.79
- Ligands: CL.31, NA.75
Ligand excluded by PLIPNA.73: 3 residues within 4Å:- Chain A: E.243, R.246
- Ligands: CL.43
Ligand excluded by PLIPNA.74: 3 residues within 4Å:- Chain A: Y.337, Y.341
- Ligands: 01.27
Ligand excluded by PLIPNA.75: 4 residues within 4Å:- Chain A: G.79, F.80, E.81
- Ligands: NA.72
Ligand excluded by PLIPNA.76: 3 residues within 4Å:- Chain A: P.235
- Ligands: NA.78, MG.101
Ligand excluded by PLIPNA.77: 4 residues within 4Å:- Chain A: S.203, H.447
- Ligands: 01.27, CL.44
Ligand excluded by PLIPNA.78: 3 residues within 4Å:- Ligands: NA.76, NA.85, MG.101
Ligand excluded by PLIPNA.79: 3 residues within 4Å:- Chain A: S.371, L.540, T.543
Ligand excluded by PLIPNA.80: 3 residues within 4Å:- Chain A: L.536, P.537
- Ligands: NA.85
Ligand excluded by PLIPNA.81: 4 residues within 4Å:- Chain A: Y.510, R.525
- Ligands: CL.30, CL.39
Ligand excluded by PLIPNA.82: 5 residues within 4Å:- Chain A: G.448, Y.449, I.451, E.452
- Ligands: 01.27
Ligand excluded by PLIPNA.83: 4 residues within 4Å:- Chain A: R.424, Y.426, D.488, P.502
Ligand excluded by PLIPNA.84: 6 residues within 4Å:- Chain A: H.223, G.323, L.324, Q.325
- Ligands: GOL.17, MG.102
Ligand excluded by PLIPNA.85: 5 residues within 4Å:- Chain A: P.235, H.405
- Ligands: NA.78, NA.80, NA.88
Ligand excluded by PLIPNA.86: 2 residues within 4Å:- Chain A: R.478
- Ligands: GOL.21
Ligand excluded by PLIPNA.87: 4 residues within 4Å:- Chain A: E.491
- Ligands: GOL.21, GOL.24, NA.92
Ligand excluded by PLIPNA.88: 4 residues within 4Å:- Chain A: H.405, P.410
- Ligands: CL.45, NA.85
Ligand excluded by PLIPNA.89: 2 residues within 4Å:- Chain A: K.348, S.438
Ligand excluded by PLIPNA.90: 3 residues within 4Å:- Chain A: E.81, S.438
- Ligands: 01.27
Ligand excluded by PLIPNA.91: 5 residues within 4Å:- Chain A: M.85, E.452, R.463
- Ligands: 01.27, CL.46
Ligand excluded by PLIPNA.92: 5 residues within 4Å:- Chain A: E.491, D.494, A.497
- Ligands: GOL.24, NA.87
Ligand excluded by PLIPNA.150: 3 residues within 4Å:- Chain B: K.332, R.525
- Ligands: CL.126
Ligand excluded by PLIPNA.151: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNA.152: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNA.153: 3 residues within 4Å:- Chain B: R.417, Q.421
- Ligands: CL.135
Ligand excluded by PLIPNA.154: 4 residues within 4Å:- Chain B: N.233, G.234, P.235
- Ligands: CL.134
Ligand excluded by PLIPNA.155: 2 residues within 4Å:- Chain B: E.94, R.152
Ligand excluded by PLIPNA.156: 4 residues within 4Å:- Chain B: H.322, G.323, L.324
- Ligands: CL.130
Ligand excluded by PLIPNA.157: 6 residues within 4Å:- Chain B: A.481, N.482, F.483, A.484, R.485, T.486
Ligand excluded by PLIPNA.158: 3 residues within 4Å:- Chain B: P.216, R.219
- Ligands: GOL.121
Ligand excluded by PLIPNA.159: 5 residues within 4Å:- Chain B: F.222, H.223
- Ligands: CL.130, CL.132, CL.133
Ligand excluded by PLIPNA.160: 3 residues within 4Å:- Chain B: G.323, R.424
- Ligands: CL.143
Ligand excluded by PLIPNA.161: 1 residues within 4Å:- Chain B: E.292
Ligand excluded by PLIPNA.162: 3 residues within 4Å:- Chain B: R.478, R.485
- Ligands: NA.183
Ligand excluded by PLIPNA.163: 5 residues within 4Å:- Chain B: E.292, S.293
- Ligands: CL.131, NA.172, NA.173
Ligand excluded by PLIPNA.164: 5 residues within 4Å:- Chain B: Y.70, P.277, A.278, Q.279
- Ligands: CL.139
Ligand excluded by PLIPNA.165: 4 residues within 4Å:- Chain B: E.39, R.45, P.50, E.51
Ligand excluded by PLIPNA.166: 3 residues within 4Å:- Chain B: K.332, D.333, G.444
Ligand excluded by PLIPNA.167: 2 residues within 4Å:- Chain B: R.525
- Ligands: SO4.116
Ligand excluded by PLIPNA.168: 3 residues within 4Å:- Chain B: V.294, F.295, F.338
Ligand excluded by PLIPNA.169: 5 residues within 4Å:- Chain B: P.235, F.295, R.296, H.405, N.406
Ligand excluded by PLIPNA.170: 2 residues within 4Å:- Chain B: N.283, H.284
Ligand excluded by PLIPNA.171: 2 residues within 4Å:- Chain B: E.243, R.246
Ligand excluded by PLIPNA.172: 2 residues within 4Å:- Chain B: E.292
- Ligands: NA.163
Ligand excluded by PLIPNA.173: 5 residues within 4Å:- Chain B: Y.341, G.342
- Ligands: CL.131, NA.163, NA.181
Ligand excluded by PLIPNA.174: 5 residues within 4Å:- Chain B: E.81, G.82, L.437, S.438
- Ligands: CL.144
Ligand excluded by PLIPNA.175: 5 residues within 4Å:- Chain B: L.22, F.65, W.102, D.134, R.136
Ligand excluded by PLIPNA.176: 1 residues within 4Å:- Chain B: Q.474
Ligand excluded by PLIPNA.177: 5 residues within 4Å:- Chain B: G.135, R.136, F.137, L.138, V.139
Ligand excluded by PLIPNA.178: 5 residues within 4Å:- Chain B: D.5, L.8, R.21, S.30, Y.105
Ligand excluded by PLIPNA.179: 1 residues within 4Å:- Chain B: A.505
Ligand excluded by PLIPNA.180: 5 residues within 4Å:- Chain B: Y.119, G.120, G.121, S.125, G.126
Ligand excluded by PLIPNA.181: 2 residues within 4Å:- Chain B: L.76
- Ligands: NA.173
Ligand excluded by PLIPNA.182: 4 residues within 4Å:- Chain B: D.333, E.396, S.399, D.400
Ligand excluded by PLIPNA.183: 5 residues within 4Å:- Chain B: N.482, R.485, T.486, E.491
- Ligands: NA.162
Ligand excluded by PLIPNA.184: 5 residues within 4Å:- Chain B: W.86, Y.337, W.439, H.447, Y.449
Ligand excluded by PLIPNA.185: 1 residues within 4Å:- Chain B: A.318
Ligand excluded by PLIP- 16 x MG: MAGNESIUM ION(Non-covalent)
MG.93: 3 residues within 4Å:- Chain A: L.9, R.16, L.17
No protein-ligand interaction detected (PLIP)MG.94: 2 residues within 4Å:- Chain A: R.534, K.538
No protein-ligand interaction detected (PLIP)MG.95: 5 residues within 4Å:- Chain A: D.74, Y.341
- Ligands: CL.42, NA.47, MG.96
No protein-ligand interaction detected (PLIP)MG.96: 5 residues within 4Å:- Chain A: Y.124, Y.337
- Ligands: CL.42, CL.44, MG.95
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:Y.124
MG.97: 6 residues within 4Å:- Chain A: D.333, S.336, E.396, S.399, W.442, M.443
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:E.396, A:W.442
MG.98: 6 residues within 4Å:- Chain A: D.384, L.386
- Chain B: Q.527
- Ligands: NA.50, SO4.116, CL.146
No protein-ligand interaction detected (PLIP)MG.99: 4 residues within 4Å:- Chain A: Q.291, R.364, P.368, Q.369
No protein-ligand interaction detected (PLIP)MG.100: 3 residues within 4Å:- Chain A: P.368, Q.369
- Ligands: NA.62
No protein-ligand interaction detected (PLIP)MG.101: 3 residues within 4Å:- Chain A: T.238
- Ligands: NA.76, NA.78
No protein-ligand interaction detected (PLIP)MG.102: 4 residues within 4Å:- Chain A: R.219, H.223, G.323
- Ligands: NA.84
No protein-ligand interaction detected (PLIP)MG.103: 3 residues within 4Å:- Chain A: L.254, H.284, H.287
No protein-ligand interaction detected (PLIP)MG.104: 4 residues within 4Å:- Chain A: N.233, E.313, Q.413
- Ligands: CL.45
3 PLIP interactions:1 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:E.313, H2O.5, H2O.5
MG.105: 2 residues within 4Å:- Chain A: Q.140, R.143
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:Q.140
MG.186: 2 residues within 4Å:- Chain B: S.371, D.372
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:D.372
MG.187: 4 residues within 4Å:- Chain B: Q.71, V.73, Q.279, V.282
No protein-ligand interaction detected (PLIP)MG.188: 2 residues within 4Å:- Chain B: A.530, R.534
No protein-ligand interaction detected (PLIP)- 1 x 02: N-Acetyl-D-Talosamine
02.118: 2 residues within 4Å:- Chain B: Q.181
- Ligands: GIV-SIA.3
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Q.181
- 1 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dias, J. et al., Crystal structure of human acetylcholinesterase in complex with the uncharged hybrid reactivator quinoline-3-hydroxy-pyridinaldoxime. To Be Published
- Release Date
- 2025-11-12
- Peptides
- Acetylcholinesterase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.75 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x GIV- SIA: N-acetyl-alpha-neuraminic acid-(2-3)-beta-L-galactopyranose(Non-covalent)
- 25 x SO4: SULFATE ION(Non-functional Binders)
- 14 x GOL: GLYCEROL(Non-functional Binders)
- 2 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
- 1 x 01: 2-[(~{Z})-hydroxyiminomethyl]-6-[4-(quinolin-4-ylamino)butyl]pyridin-3-ol
- 43 x CL: CHLORIDE ION(Non-functional Binders)
- 82 x NA: SODIUM ION(Non-functional Binders)
- 16 x MG: MAGNESIUM ION(Non-covalent)
- 1 x 02: N-Acetyl-D-Talosamine
- 1 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dias, J. et al., Crystal structure of human acetylcholinesterase in complex with the uncharged hybrid reactivator quinoline-3-hydroxy-pyridinaldoxime. To Be Published
- Release Date
- 2025-11-12
- Peptides
- Acetylcholinesterase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B